These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

232 related items for PubMed ID: 2576228

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Synthesis and binding properties of the fluorinated substituted benzamide [3H]NCQ 115, a new selective dopamine D2 receptor ligand.
    Hall H, Högberg T, Halldin C, Bengtsson S, Wedel I.
    Eur J Pharmacol; 1991 Aug 16; 201(1):1-10. PubMed ID: 1686586
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dopamine D2 receptors selectively labeled by a benzamide neuroleptic: [3H]-YM-09151-2.
    Niznik HB, Grigoriadis DE, Pri-Bar I, Buchman O, Seeman P.
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun 16; 329(4):333-43. PubMed ID: 2863760
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Effects of chronic neuroleptic treatment on agonist affinity states of the dopamine-D2 receptor in the rat brain.
    Hall H, Sällemark M.
    Pharmacol Toxicol; 1987 May 16; 60(5):359-63. PubMed ID: 2886988
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum.
    Hess EJ, Battaglia G, Norman AB, Iorio LC, Creese I.
    Eur J Pharmacol; 1986 Feb 11; 121(1):31-8. PubMed ID: 2869957
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the in vitro receptor binding properties of N-[3H]methylspiperone and [3H]raclopride to rat and human brain membranes.
    Hall H, Wedel I, Halldin C, Kopp J, Farde L.
    J Neurochem; 1990 Dec 11; 55(6):2048-57. PubMed ID: 1977888
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Endogenous dopamine lowers the dopamine D2 receptor density as measured by [3H]raclopride: implications for positron emission tomography of the human brain.
    Seeman P, Guan HC, Niznik HB.
    Synapse; 1989 Dec 11; 3(1):96-7. PubMed ID: 2521961
    [No Abstract] [Full Text] [Related]

  • 18. Differential regulation of dopamine receptors after chronic typical and atypical antipsychotic drug treatment.
    Tarazi FI, Florijn WJ, Creese I.
    Neuroscience; 1997 Jun 11; 78(4):985-96. PubMed ID: 9174067
    [Abstract] [Full Text] [Related]

  • 19. Dopamine D-2 receptors in canine brain: ionic effects on [3H]neuroleptic binding.
    Jarvie KR, Niznik HB, Seeman P.
    Eur J Pharmacol; 1987 Dec 01; 144(2):163-71. PubMed ID: 2893738
    [Abstract] [Full Text] [Related]

  • 20. Dopamine D2 receptors labeled with [3H]raclopride in rat and rabbit brains. Equilibrium binding, kinetics, distribution and selectivity.
    Dewar KM, Montreuil B, Grondin L, Reader TA.
    J Pharmacol Exp Ther; 1989 Aug 01; 250(2):696-706. PubMed ID: 2527300
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.